Navigation Links
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Date:11/28/2008

INDIANAPOLIS, Nov. 28 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application in the first half of 2009, adding data from a recently completed positive study in chronic osteoarthritis pain of the knee.

The decision does not affect duloxetine's FDA-approved indications for major depressive disorder, generalized anxiety disorder, management of diabetic peripheral neuropathic pain and management of fibromyalgia.

Lilly submitted the chronic pain application in the second quarter of 2008 based primarily on outcomes of three clinical trials: one positive study in chronic osteoarthritis pain of the knee(i) and two studies(ii,iii), -- one positive and one that is supportive but didn't meet its primary endpoint -- in chronic low back pain. In discussions between Lilly and the FDA, agency reviewers raised questions about efficacy and dosing that revolved primarily around statistical methodology and study design.

"This was a difficult decision, but we believe the updated data package will give the FDA a broader basis for reviewing our application," said John Hayes, M.D., a Lilly Research Laboratories vice president at Lilly.

Chronic pain affects more than 50 million Americans(iv) and pain is a major cause of work absenteeism, underemployment and unemployment.(v,vi,vii,viii)

About Duloxetine

Serotonin and norepinephrine in the brain and spinal cord are believed to both mediate core mood symptoms and help regulate the perception of pain. Based on preclinical studies, Duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine that is bel
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
2. Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
3. Lilly Announces Initiation of Second Global Phase III Trial of Investigational Alzheimers Disease Compound
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Phase II Data on Lillys Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimers Disease
6. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
7. Lilly and TransPharma Medical Announce Licensing and Development Agreement
8. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
9. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
10. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
11. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Mapi ... Regulatory challenges through the drug development and commercialization process. ... include Global Strategic Regulatory services with the addition of ... previously announced acquisition . CanReg is one of ... exclusively to regulatory affairs for life sciences companies. With ...
(Date:3/3/2015)... MENLO PARK, Calif. , March 3, 2015   ... a biopharmaceutical company focused on developing and commercializing proven cancer ... will be presenting at the 27th Annual ROTH Conference ... Laguna Niguel , in Dana Point, ... DelMar,s president and CEO, will present on Tuesday, March 10, ...
(Date:3/3/2015)... -- STAAR Surgical Company (NASDAQ: STAA ) a leading ... for the eye, has named Caren Mason President ... elected to STAAR,s Board of Directors in June 2014, and ... Regulatory Committee in September 2014, replaces Barry G. Caldwell ... Ms. Mason joins STAAR after most recently serving as ...
Breaking Medicine Technology:Mapi incorporates Strategic Regulatory Services to support life-science product Commercialization and Health Research 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 2DelMar Pharmaceuticals to Present at the 27th Annual ROTH Conference on March 10, 2015 3Caren Mason Appointed President & CEO of STAAR Surgical Company 2Caren Mason Appointed President & CEO of STAAR Surgical Company 3Caren Mason Appointed President & CEO of STAAR Surgical Company 4Caren Mason Appointed President & CEO of STAAR Surgical Company 5
... , , ... data from a clinical study of ENB-0040, a bone ... of hypophosphatasia (HPP). After six months of treatment with ... improvements in bone mineralization, correction of skeletal defects, better ...
... , MONMOUTH JUNCTION, N.J., Sept. 14 Transave, ... trial in non-cystic fibrosis (CF) bronchiectasis patients for its lead ... Phase II data indicated that ARIKACE, delivered once daily for ... as measured by patient and physician reported outcomes and reduction ...
Cached Medicine Technology:Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 2Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia 3Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 2Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 3Transave Announces Positive Phase II Results For Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections 4
(Date:3/3/2015)... Venato, a secure cloud-based credential ... flagship software solution now provides an automated mechanism ... to the National Healthcare Safety Network (NHSN). ... require that hospitals submit healthcare personnel (HCP) influenza ... May 15 for each influenza season in order ...
(Date:3/3/2015)... San Rafael, CA (PRWEB) March 03, 2015 ... basketball talent. Global sports icon, Michael Jordan, brought a level ... before, and has yet to experience again since his Chicago ... frenzy in city that exists to this day. This era ... the premier global basketball brand. Due to this rich basketball ...
(Date:3/3/2015)... March 03, 2015 United Benefit Advisors ... is pleased to welcome The Gehring Group, Inc. as ... services for more than 20 years, The Gehring Group ... and risk management consulting firm that serves organizations in ... risk management programs. , Based in Palm ...
(Date:3/3/2015)... March 03, 2015 After the holiday ... lifestyle of fitness and exercise. Community Health Center of ... presenting 6 ways that families in Everett, Marysville, and ... winter months. , CHC says, “While it’s relatively ... and steamed veggies, many families wonder how to keep ...
(Date:3/3/2015)... Extend Nutrition, a leading nutritional snack company with ... consumed at the next meal by an average of 21%* ... lifestyle changes needed and no program to abide by. Consumers ... starter kit contains 60 servings of nutritional bars, shakes, and ... healthy fat and complex carbohydrates that helps to control blood ...
Breaking Medicine News(10 mins):Health News:Venato Incorporates Automated NHSN Reporting Tool to Their Software Solution 2Health News:US Sports Camps and Nike Basketball Camps Add Five New Locations In and Around Chicago for the Summer of 2015 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 2Health News:United Benefit Advisors Welcomes New Partner Firm The Gehring Group, Inc. 3Health News:6 Wintertime Weight Loss Tips for Family Fitness Presented by Community Health Center of Snohomish County in Recent Article 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 2Health News:Snack Your Way to a Smaller Waistline with Extend Nutrition’s New “Snack-2-Health Kit” 3
... pediatric study conducted by Vinay Nadkarni, MD, and Peter ... at The Children's Hospital of Philadelphia it is found ... This is a life-threatening disordered heart rhythms that may ... develops later during the arrest at the time of ...
... endorsed the plan for the closure of two facilities which ... in the region//. NHS Borders has since been planning the ... ,Shutting down the Jedburgh Cottage Hospital and the cottage hospital ... October. The 60 staff involved are expected to be deployed ...
... According to latest figures revealed in Ireland, suicide is the most ... the age of 35years//. There were 431 registered suicides in 2005,with ... , The HSE today appealed to the media not to ... were preventable. , , “We are ...
... as of now 15 people have died. Hence the ... to fight polio. // This campaign would cost 395 ... the health ministry. On the whole about 96 people ... African country. Namibian President Hifikepunye Pohamba, asked the people ...
... here used an animal vaccine supplied to it "by ... a doctor //and storekeeper, authorities said Wednesday. ... Laboratory Pvt Ltd, which provided the vaccine to the ... doctors at the hospital found out that medicines meant ...
... juvenile dermatomyositis (JDM), a protein present in chronic inflammatory ... //to trigger T-cells response – which is associated with ... Elst finds. ,The specific response has earlier ... little is known about the role of HSP60 in ...
Cached Medicine News:Health News:Proteins – A New Way to Treat Children's Muscle Diseas 2
... Oxygen Conservation Device. Bypass ... ,6200 Accessories: , OCD870C ... CGA 540 Regulator , OCD2001-18 ... Booklet , CP2140 Vertical M-6 ...
... with Accutrol is similar in design to ... it incorporates a temperature probe at the ... probe can accurately determine the patient's core ... temperature accuracy comparable to a pulmonary artery ...
... These markers are available with 16 or 24 circular ... diameter, and an outer 9.5mm diameter. The markers are ... one single step for a 16 or 24 running ... points on the cornea to achieve a precise and ...
... Shafts For Insertion Through A 1.0mm Incision., ... ... A More Comfortable Approach., ,Recessed Jaws For ... For Protection Of Jaws During Sterilization., ,Reusable, ...
Medicine Products: